Advertisement
top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:637-647, doi:10.1016/j.jcmg.2008.08.009
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipinski, M. J.
Right arrow Articles by Fayad, Z. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lipinski, M. J.
Right arrow Articles by Fayad, Z. A.

Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis

Michael J. Lipinski, MD*,{dagger},{ddagger},§,||, Juan C. Frias, PhD*,{dagger}, Vardan Amirbekian, MD*,{dagger},#, Karen C. Briley-Saebo, PhD*,{dagger}, Venkatesh Mani, PhD*,{dagger}, Daniel Samber, PE*,{dagger}, Antonio Abbate, MD§, Juan Gilberto S. Aguinaldo, MD*,{dagger}, Davis Massey, DDS, MD, PhD**, Valentin Fuster, MD, PhD{ddagger}, George W. Vetrovec, MD§, Zahi A. Fayad, PhD*,{dagger},{ddagger},*

* Translational and Molecular Imaging Institute, Mount Sinai Medical Center, New York, New York
{dagger} Imaging Science Laboratories, Department of Radiology, Mount Sinai Medical Center, New York, New York
{ddagger} The Zena and Michael A. Wiener Cardiovascular Institute, The Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Department of Internal Medicine, Division of Cardiology, Mount Sinai Medical Center, New York, New York
§ VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia
|| Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia
Instituto de Ciencia Molecular, University of Valencia, Valencia, Spain
# Department of Radiology, Brigham and Womens Hospital, Boston, Massachusetts
** Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia

* Reprint requests and correspondence: Dr. Zahi A. Fayad, Mount Sinai School of Medicine, One Gustave L. Levy Place, Imaging Science Laboratories, Box 1234, New York, New York 10029 (Email: zahi.fayad{at}mssm.edu).

Objectives: We sought to determine whether gadolinium (Gd)-containing lipid-based nanoparticles (NPs) targeting the macrophage scavenger receptor-B (CD36) improve cardiac magnetic resonance (CMR) detection and characterization of human atherosclerosis.

Background: Gd-containing lipid-based NPs targeting macrophages have improved MR detection of murine atherosclerosis.

Methods: Gadolinium-containing untargeted NPs, anti-CD36 NPs, and nonspecific Fc-NPs were created. Macrophages were incubated with fluorescent targeted and nontargeted NPs to determine uptake via confocal microscopy and inductively coupled plasma mass spectroscopy (ICP-MS) quantified Gd uptake. Human aortic specimens were harvested at autopsy. With a 1.5-T scanner, T1, T2, and PDW 3-dimensional scans were performed along with post-contrast scans after 24 h incubation. The T1 and cluster analyses were performed and compared with immunohistopathology.

Results: The NPs had a mean diameter of 125 nm and 14,900 Gd-ions, and relaxivity was 37 mmol/l–1s–1 at 1.5-T and 37°C. Confocal microscopy and ICP-MS demonstrated significant in vitro macrophage uptake of targeted NPs, whereas non-targeted NPs had minimal uptake. On T1 imaging, targeted NPs increased contrast-to-noise ratio (CNR) by 52.5%, which was significantly greater than Fc-NPs (CNR increased 17.2%) and nontargeted NPs (CNR increased 18.7%) (p = 0.001). Confocal fluorescent microscopy showed that NPs target resident macrophages, whereas the untargeted NPs and Fc-NPs are found diffusely throughout the plaque. Targeted NPs had a greater signal intensity increase in the fibrous cap compared with non-targeted NPs.

Conclusions: Macrophage-specific (CD36) NPs bind human macrophages and improve CMR detection and characterization of human aortic atherosclerosis. Thus, macrophage-specific NPs could help identify high-risk human plaque before the development of an atherothrombotic event.

Key Words: atherosclerosis • CD36 • macrophage • magnetic resonance imaging • nanoparticles

Abbreviations and Acronyms
  Apo = apolipoprotein
  CD204 = a class A macrophage scavenger receptor
  CD36 = a class B macrophage scavenger receptor
  CMR = cardiac magnetic resonance
  CNR = contrast-to-noise ratio
  DAPI = 4',6'-diamidino-2-phenylindole hydrochloride
  DPPE-NBD = 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-7-nitro-2-1,3-benzoxadiazol-4-yl
  Gd = gadolinium
  ICP-MS = inductively coupled plasma mass spectroscopy
  MSR = macrophage scavenger receptor
  NP = nanoparticle
  PBS = phosphate-buffered solution
  PDW = proton-density-weighted
  RPE = phycoerythrin
  SNR = signal-to-noise ratio
  SPIO = superparamagnetic iron oxide particle






Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link